&w=3840&q=100)
Weak guidance, higher costs to weigh on Sun Pharma's FY26 outlook
Sun Pharma's FY26 revenue guidance disappoints Street expectations as higher specialty product costs in the US prompt brokerages to cut earnings estimates
Ram Prasad Sahu
Listen to This Article
Despite a healthy performance in the fourth quarter of financial year 2024-25 (Q4FY25), the stock of India's largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on Friday due to a muted guidance. The company has guided for a high single-digit revenue growth for FY26, which is below what the Street was working with. This coupled with higher expenses related to the launch of specialty products in the US market has prompted brokerages to cut their earnings estimates for FY26 by 4-8 per cent. The stock was the only loser in the Sensex, shedding 2 per cent,
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
20 minutes ago
- Economic Times
ET Market Watch: Sensex at 81K, Nifty Near 25K; RBI Rate Cut Hopes Boost Sentiment
Transcript Hi, you're listening to ET Markets Radio, I am your host Neha V Mahajan. Welcome to a fresh episode of ET Market Watch -- where we bring you the latest news from the world of stock markets every single day. Let's get to it:Markets ended on a high note today. The Sensex jumped 443 points to close at 81,442, and Nifty rose 131 points to end at 24,750 — after briefly flirting with the 24,900 mark during the driving the rally?- Pharma and Reliance Industries led the charge, while Nifty Realty and Pharma gained the most—up 1.75% and 1.3% respectively. IT and Metal followed with modest gains.- Broader markets were upbeat too—Smallcaps up 1%, Midcaps up 0.7%.- Rs 2.4 lakh crore was added to investor wealth today, pushing BSE's market cap to Rs 447.61 lakh the global push:A weaker U.S. dollar and falling Treasury yields helped boost sentiment. The 10-year U.S. yield fell to 4.355%, raising hopes of a rate cut by the Fed. That's great news for emerging markets like home: All eyes are on the RBI's policy meeting tomorrow. Markets are betting on a 25 bps rate cut—that would make it the third cut in a row, a big boost for liquidity and are back in buying mode, pumping in over Rs 1,000 crore, while DIIs continued their buying streak, investing over Rs 2,500 finally, crude oil prices dipped—Brent at $64.85—thanks to weak U.S. demand data and Saudi price cuts.A softer dollar, falling yields, rate cut hopes, and foreign inflows—India's market bulls have plenty to cheer!
Economic Times
an hour ago
- Economic Times
Fed should cut interest rate by a full point, Trump says
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Time of India
2 hours ago
- Time of India
ET Market Watch: Sensex at 81K, Nifty Near 25K; RBI Rate Cut Hopes Boost Sentiment
Transcript Hi, you're listening to ET Markets Radio, I am your host Neha V Mahajan. Welcome to a fresh episode of ET Market Watch -- where we bring you the latest news from the world of stock markets every single day. Let's get to it: Markets ended on a high note today. The Sensex jumped 443 points to close at 81,442, and Nifty rose 131 points to end at 24,750 — after briefly flirting with the 24,900 mark during the day. What's driving the rally? - Pharma and Reliance Industries led the charge, while Nifty Realty and Pharma gained the most—up 1.75% and 1.3% respectively. IT and Metal followed with modest gains. - Broader markets were upbeat too—Smallcaps up 1%, Midcaps up 0.7%. - Rs 2.4 lakh crore was added to investor wealth today, pushing BSE's market cap to Rs 447.61 lakh crore. Now the global push: A weaker U.S. dollar and falling Treasury yields helped boost sentiment. The 10-year U.S. yield fell to 4.355%, raising hopes of a rate cut by the Fed. That's great news for emerging markets like India. Back home: All eyes are on the RBI's policy meeting tomorrow. Markets are betting on a 25 bps rate cut—that would make it the third cut in a row, a big boost for liquidity and growth. FIIs are back in buying mode, pumping in over Rs 1,000 crore, while DIIs continued their buying streak, investing over Rs 2,500 crore. And finally, crude oil prices dipped—Brent at $64.85—thanks to weak U.S. demand data and Saudi price cuts. A softer dollar, falling yields, rate cut hopes, and foreign inflows—India's market bulls have plenty to cheer!
